M. Geoffrey Parker

Affiliations

  • Chief Financial Officer at Allogene Therapeutics Inc. (ALLO), 2024-03-07
  • at Better Therapeutics Inc. (BTTX), 2023-12-20
  • Director at Perrigo Co Plc (PRGO), 2023-06-14
  • Director at Chemocentryx Inc. (CCXI), 2022-10-24
  • Coo, Cfo And Evp at Tricida Inc. (TCDA), 2022-03-02
  • Director at Genomic Health Inc (GHDX), 2019-11-15
  • Director at Sunesis Pharmaceuticals Inc (SNSS), 2017-06-02
  • Executive Vice President & Cfo at Anacor Pharmaceuticals Inc. (ANAC), 2015-03-23
  • Director at Genoptix Inc (GXDX), 2011-03-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALLO $3.60 190 819,590 2024-01-30 Filing
BTTX $0.73 685,025 1,028,055 2023-07-27 Filing
PRGO $33.06 10,000 Director 25,879 2023-06-13 Filing
BTTX $0.83 303,030 Director 343,030 2023-04-10 Filing
PRGO $38.05 5,000 Director 15,879 2023-03-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CCXI $55.89 13,330 Director 12,690 2021-03-05 Filing
CCXI $56.78 16,670 Director 26,020 2021-03-05 Filing
CCXI $60.20 1,910 Director 42,690 2021-03-04 Filing
CCXI $38.21 860 Director 49,600 2020-03-23 Filing
CCXI $37.40 13,959 Director 50,460 2020-03-23 Filing